Shares magazine
Magazine archive
Great Ideas
Tiny building materials firm could become £1bn player
Thursday 26 Oct 2017An under the radar building materials company is worth nearly 2.5 times its current market value, according to analysts. Now is the perfect time to invest in SigmaRoc ( SRC:AIM ) as its third acquisition proves it can find good targets at decent prices. The company joined the stock market at the...
We don’t believe Carnival is sailing into troubled waters
Thursday 19 Oct 2017Cruise operator Carnival ( CCL ) is a resilient company which is suffering temporary setbacks from events out of its control. We believe that 2018 is set to put the cruise liner on a stronger footing as earnings are forecast to show a considerable improvement on 2017’s anticipated numbers. Buy at £...
Ascential’s China Money boost
Thursday 19 Oct 2017Now is the perfect time to invest in media group Ascential ( ASCL ) as there are several potential share price catalysts on the horizon. We’re particularly excited about the launch next year of its Money 20/20 event in China which could have a significant boost to earnings. Nearer term, the company...
Reckitt remains full of vitality
Thursday 12 Oct 2017Share price weakness at consumer health and hygiene giant Reckitt Benckiser ( RB. ) presents a not-to-be-missed buying opportunity for seekers of high-quality, defensive stocks. Short-term issues currently weigh on sentiment towards the Dettol , Durex , Gaviscon and Cillit Bang brands owner, yet we...
Market is too gloomy on Vodafone
Thursday 12 Oct 2017One of the largest communications network providers, Vodafone ( VOD ) supplies more than 523m mobile customers worldwide. The FTSE 100 mega-cap is also a staple portfolio stock for thousands of investors thanks to its substantial dividend. This year’s expected income of around €0.15 per share (the...
Allergy Therapeutics is really exciting
Thursday 05 Oct 2017For people who love the warmer months, allergies can really get you down, whether it’s the constant sneezing, the itchy eyes or the endlessly runny nose while sprinting for the bus. One company trying to eradicate the frustrating side-effects of allergies is Allergy Therapeutics ( AGY:AIM ) , a...
Fill up on Greencore while the market is feasting elsewhere
Thursday 05 Oct 2017Share price weakness at sandwiches, salads and chilled soups supplier Greencore ( GNC ) presents a tasty buying opportunity for growth and income seekers. The convenience foods maker’s margins and cash flows have come under pressure in recent years due to high levels of investment, yet Greencore is...
Engineer Molins is swimming in cash
Thursday 28 Sep 2017This is a special situation investment and one which we believe is capable of creating substantial returns if management can successfully execute their plans. Molins ( MLIN:AIM ) has a long history supplying machinery to the tobacco industry; that part of the business has now been sold for £30m...
L&G is a cracking value and income play
Thursday 28 Sep 2017Investors interested in well-known names that pay good dividends but put off by sky high valuations need look no further than Legal & General ( LGEN ) . The company offers a ‘one-stop-shop’ for an ageing population in developed nations by offering pensions, insurance, investments and savings...
M.P. Evans has real growth potential
Thursday 21 Sep 2017Investors seeking a strong profit and dividend growth story with M&A optionality thrown in should cultivate a position in Indonesian palm oil producer M.P. Evans ( MPE:AIM ) . Boasting one of the industry’s youngest estates, MPE has superb earnings visibility for the coming decade, while the...